证券代码：603439 证券简称：贵州三力 公告编号：2025-044 贵州三力制药股份有限公司 关于回购注销部分限制性股票减资暨通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原因 二、需债权人知晓的相关信息 的第四届董事会第十一次会议和第四届监事会第十次会议，审议通过了《关于回 购注销部分限制性股票的议案》，同意公司以自有资金回购注销2024年限制性股 票激励计划中部分已获授但尚未解除限售的限制性股票合计60,000股。具体内容 详见公司2025年3月29日于上海证券交易所网站（www.sse.com.cn）披露的《贵 州三力制药股份有限公司关于回购注销部分限制性股票的公告》（公告编号： 暨通知债权人的公告》（公告编号：2025-008）。截止本公告披露日，相关股份 尚未完成注销。 第十一次会议，审议通过了《关于2021年限制性股票激励计划第三个解除限售期 解除限售条件未成就暨回购注销的议案》，同意公司以自有资金回购注销2021 年限制性股票激励计划第三个解除限售期中已获授但解除限售条件未 ...

证券代码：002402 证券简称：和而泰 公告编号：2025-053 深圳和而泰智能控制股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 深圳和而泰智能控制股份有限公司（以下简称"公司"）于2025年7月29日召开第 六届董事会第二十六次会议和第六届监事会第二十四次会议审议通过了《关于回购注 销部分已授予但尚未解除限售的限制性股票暨减资的议案》，公司董事会同意对4名因 个人原因离职不再符合激励条件的激励对象已授予但尚未解除限售的限制性股票共 尚需提交公司股东大会审议，现将有关情况公告如下： 一、 股权激励计划已履行的相关审议程序 议，审议通过了《关于<2022年限制性股票激励计划（草案）>及其摘要的议案》等相关 议案，公司独立董事对此发表了同意的独立意见，北京君合（杭州）律师事务所就此事 项 出 具 了 法 律 意 见 书 。 具 体 内 容 详 见 2022 年 12 月 2 日 登 载 于 巨 潮 资 讯 网 （www.cninfo.com.cn）的相关公告文件。 励计划激励对象名单》，公示时间为2022年12月2日-2022年12月12日，公 ...

Core Viewpoint - The company has completed the repurchase and cancellation of part of the restricted stock under the 2023 stock option and restricted stock incentive plan, with a total repurchase amount of RMB 1,836,245.60, resulting in a reduction of the total share capital [1][10][14]. Summary by Sections Stock Incentive Plan Overview - The company approved the 2023 stock option and restricted stock incentive plan on July 10, 2023, and the plan was subsequently authorized by the shareholders' meeting [1][2][3]. - The plan includes performance assessment criteria for the release of restricted stocks, with specific performance targets set for the years 2023 to 2025 [10]. Repurchase and Cancellation Details - The repurchase and cancellation of restricted stocks were conducted due to the failure to meet the performance targets for the year 2024, which required a revenue growth rate of no less than 44% compared to 2022 [10][11]. - The total number of restricted stocks repurchased was 8,400 shares, and the adjusted repurchase price was set at RMB 5.56 per share [12][14]. Changes in Share Capital Structure - Following the repurchase, the company's share capital structure changed, with the number of restricted shares with limited sale conditions decreasing from 24,243,087 to 23,912,827 shares [14]. - The total number of shares after the repurchase is 867,357,451 shares, maintaining compliance with listing requirements [14]. Financial Impact - The repurchase and cancellation of restricted stocks will not have a substantial impact on the company's financial status or operational results, nor will it affect the ongoing implementation of the incentive plan [14].

Core Viewpoint - The company, Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., is implementing a buyback and cancellation of 144,094 restricted stocks due to the departure of three employees, which represents 5.95% of the total stock under the incentive plan and 0.02% of the company's total share capital [1][2]. Group 1: Buyback and Cancellation Details - The buyback and cancellation are based on the provisions of the "Incentive Plan" and the "Management Measures for Equity Incentives of Listed Companies," which stipulate that restricted stocks cannot be released from restrictions if the employee has left the company [2][3]. - The total amount for the buyback is 1,186,181.80 yuan, sourced from the company's own funds [2][3]. - The cancellation of the stocks is expected to be completed by July 29, 2025, with the company having opened a dedicated securities account for this purpose [3]. Group 2: Impact on Share Capital Structure - Following the cancellation, the company's total share capital will decrease from 941,140,609 shares to 940,996,515 shares [3][4]. - The cancellation will not affect the controlling shareholder or the actual controller, and the company's equity distribution will still meet the listing requirements [4]. Group 3: Legal Compliance and Commitments - The board of directors confirmed that the decision-making process and information disclosure comply with relevant laws and regulations, ensuring no harm to the rights of the incentive objects or creditors [4][5]. - The company has committed to handling any disputes arising from this buyback and cancellation responsibly [4][5].

Core Viewpoint - Shenzhen Suoling Industrial Co., Ltd. plans to repurchase and cancel 400,000 restricted stocks at a price of 2.60 RMB per share due to the departure of one incentive object under the 2023 incentive plan [10][12]. Group 1: Repurchase and Cancellation Details - The repurchase involves 400,000 restricted stocks that have been granted but not yet released from the lock-up period [10]. - The repurchase price is set at 2.60 RMB per share, which aligns with the granting price specified in the incentive plan [10]. - The decision to repurchase has been approved by the company's board and supervisory committee [10][12]. Group 2: Legal Compliance and Opinions - The legal opinion confirms that the repurchase and cancellation comply with relevant laws, including the Company Law and Securities Law [10][12]. - The law firm has conducted thorough verification of the facts and documents related to the incentive plan and has concluded that the repurchase is legitimate and authorized [2][10]. - The company is required to continue fulfilling its information disclosure obligations as the incentive plan progresses [12].

Group 1 - The meeting of the supervisory board of Shanghai Jinhua Adhesive New Materials Co., Ltd. was held on July 17, 2025, and was legally convened with all three supervisors present [1][2] - The supervisory board approved the proposal to cancel stock options and repurchase restricted stocks for two incentive targets who no longer meet the qualification criteria, involving a total of 32,000 restricted stocks and 30,000 stock options [1][2] - The voting results for the proposal were unanimous, with 3 votes in favor and no votes against or abstaining [2]

Group 1 - The company is holding its second extraordinary general meeting of shareholders in 2025 on July 24 at 14:30 in Hangzhou, Zhejiang Province [3][4] - The meeting will include a report on attendance, discussion of agenda items, and a vote on the proposal to repurchase and cancel certain restricted stocks from the 2024 incentive plan [4][5] - The company emphasizes the importance of maintaining order and protecting the rights of shareholders during the meeting, with specific requirements for attendance and voting procedures [2][6] Group 2 - The proposal involves repurchasing and canceling 320,000 shares of restricted stock due to three incentive plan participants leaving the company, which represents 3.29% of the stock involved in the incentive plan and 0.04% of the total share capital [5][6] - The repurchase price is adjusted from 11.84 RMB per share to 10.46 RMB per share, with a total repurchase amount of 3,347,200 RMB sourced from the company's own funds [5][6] - The company states that the repurchase will not change the control of the company and will not have a substantial impact on its financial status or operational results [6]

Core Viewpoint - The company, Fujian Haitong Development Co., Ltd., has announced the repurchase and cancellation of a portion of restricted stocks due to the departure of certain incentive plan participants, resulting in a total of 170,360 shares being repurchased and canceled [1][2][3]. Summary by Sections Repurchase and Cancellation Reasons - The board of directors approved the repurchase and cancellation of restricted stocks and stock options due to the departure of incentive plan participants who no longer qualify [1][2]. Details of Repurchase and Cancellation - A total of 17,036 shares will be repurchased and canceled, including 10,360 shares from the 2023 incentive plan and 5,000 shares from the 2024 plan [1][2]. - For the 2023 incentive plan, 1,036 shares will be canceled due to one participant's departure, leaving 3,221,960 shares remaining [2]. - For the 2024 incentive plan, 16,000 shares will be canceled due to three participants' departures, leaving 5,162,500 shares remaining [3]. Share Capital Structure Changes - The share capital structure will change as follows: - Restricted shares before: 649,854,992; after: 649,684,632 - Unrestricted shares remain unchanged at 275,526,296 - Total shares before: 925,381,288; after: 925,210,928 [5]. Compliance and Legal Opinions - The company confirms that the repurchase and cancellation procedures comply with relevant laws and regulations, ensuring no harm to the rights of incentive participants or creditors [5][6]. - Legal opinions affirm that the actions taken are in accordance with the Company Law and Securities Law, and do not harm the interests of the company or its shareholders [6].

证券代码：603368 证券简称：柳药集团 公告编号：2025-052 转债代码：113563 转债简称：柳药转债 广西柳药集团股份有限公司 关于限制性股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 回购注销原因：广西柳药集团股份有限公司（以下简称"公司"）2023 年限制性股票激励计划（以下简称"本激励计划"）中的 1 名预留授予激励对象 因个人原因离职而不再具备激励资格，公司决定对其持有的已获授但尚未解除限 售的 3,000 股限制性股票予以回购注销；因公司决定终止实施本激励计划，公司 需回购注销除上述 1 名离职激励对象以外的 181 名激励对象已获授但尚未解除限 售的 1,692,050 股限制性股票。 ● 本次注销股份的有关情况： 回购股份数量 注销股份数量 注销日期 一、本次限制性股票回购注销的决策与信息披露 公司于 2025 年 4 月 28 日召开第五届董事会第二十六次会议和第五届监事会 第二十次会议，并于 2025 年 5 月 19 日召开 2025 年第一次临 ...

证券代码：605060 证券简称：联德股份 公告编号：2025-024 杭州联德精密机械股份有限公司 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州联德精密机械股份有限公司（以下简称 "公司"）于2025年4月21日召开 第三届董事会第十次会议及第三届监事会第十次会议，审议通过了《关于回购注 销2022年限制性股票激励计划部分限制性股票的议案》。2025年6月19日，公司 对50名激励对象已获授但尚未解除限售的592,000股限制性股票完成回购注销， 因此公司总股本由241,184,000股变为240,592,000股。具体内容详见公司于2025 年6月17日在上海证券交易所网站（www.sse.com.cn）披露的《杭州联德精密机 械股份有限公司关于2022年限制性股票激励计划部分限制性股票回购注销实施 的公告》（公告编号：2025-019）。公司于2025年6月19日在中国证券登记结算 有限责任公司上海分公司办理完成登记工作，公司股份总数由241,184,000股减少 至240,592,0 ...